Regulatory News
Monday, March 28, 2016
Valeant CEO subpoenaed to testify before U.S. Senate panel
WASHINGTON, March 28 (Reuters) - The chief executive of
Valeant Pharmaceuticals International Inc, which is
under scrutiny for dramatically hiking the price of older drugs,
has been summoned to...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment